13F filer

HighMark Wealth Management

As of Jun 30, 2026 Filed Aug 12, 2026 CIK 1802451 SEC filings ↗
13F Value
$298.5M
Positions
565
Top Position
IVV27.6%
Top 5
49.7%

Latest filing changes

vs Mar 31, 2026
2 SIBN Si Bone +165.9%+$4.3M
3 NPCE Neuropace +158.7%+$1.6M
5 NEO Neogenomics +5.6%+$477K
Holdings565
# Trend (4Q)
1 IVV 27.6% $82.3M -6.0% 109.9K 31.0% ETF
2 FHLC 6.6% $19.7M >999% 254.4K <0.1% ETF
3 AXGN 5.3% $15.8M -1.0% 341.4K 4.7% Common Stock
4 IWM 5.1% $15.3M -6.6% 51.0K 5.5% ETF
5 EFV 5.1% $15.2M -9.6% 199.2K 6.7% ETF
6 IJR 4.5% $13.3M -0.9% 89.9K 4.6% ETF
7 VOO 3.6% $10.7M -5.9% 15.5K 4.0% ETF
8 NEO 3.0% $8.9M +5.6% 612.5K 1.8% Common Stock
9 IUSV 2.8% $8.3M -6.2% 75.5K 3.3% ETF
10 SIBN 2.3% $6.9M +165.9% 425.0K 0.8% Common Stock
11 DWAS 2.0% $5.9M -0.7% 46.5K 1.9% ETF
12 WFC 1.9% $5.7M +0.1% 68.6K 2.2% Common Stock
13 IJH 1.6% $4.8M +2.8% 62.4K 1.7% ETF
14 APGE 1.4% $4.3M NEW 32.3K — Common Stock
15 TWST 1.3% $4.0M -0.7% 39.0K 0.8% Common Stock
16 DUOT 1.2% $3.5M NEW 289.9K — Common Stock
17 TLT 1.0% $3.1M +1.0% 36.1K 1.3% ETF
18 MASS 1.0% $3.0M +6.4% 339.8K 0.8% Common Stock
19 ANAB 0.9% $2.7M -57.8% 39.7K 2.1% Common Stock
20 NPCE 0.9% $2.6M +158.7% 163.0K 0.3% Common Stock
Change compares with the prior filing. Prior % is the share of the portfolio in that filing. Trend shows the quantity held in each of the last four filings: green rose, red fell, grey unchanged.
Exited in Latest Filing36
# Holding Prior % Prior Value Change Prior Quantity Trend (4Q) Type
Compared with the immediately prior published filing (Mar 31, 2026). Prior values are shown for context and are not included in current totals.